|
US12312375B2
(en)
|
2017-10-09 |
2025-05-27 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US11447510B2
(en)
|
2017-10-09 |
2022-09-20 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2572023A
(en)
*
|
2017-10-09 |
2019-09-18 |
Compass Pathways Ltd |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US10519175B2
(en)
|
2017-10-09 |
2019-12-31 |
Compass Pathways Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
DE202018006384U1
(de)
|
2017-10-09 |
2020-03-19 |
Compass Pathways Limited |
Herstellung von Psilocybin, verschiedenen polymorphen Formen, Zwischenprodukten, Formulierungen und deren Verwendung
|
|
GB2571696B
(en)
*
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
CN111491919A
(zh)
*
|
2017-10-09 |
2020-08-04 |
指南针路径有限公司 |
赛洛西宾、不同多晶型形式、中间体、配制品的制备及其用途
|
|
JP2020536960A
(ja)
*
|
2017-10-09 |
2020-12-17 |
コンパス パスファインダー リミテッド |
シロシビン、異なる多形形態、中間体、調合物の調製及びそれらの使用
|
|
US10947257B2
(en)
|
2017-10-09 |
2021-03-16 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US10954259B1
(en)
|
2017-10-09 |
2021-03-23 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2588506A
(en)
*
|
2017-10-09 |
2021-04-28 |
Compass Pathfinder Ltd |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US11149044B2
(en)
|
2017-10-09 |
2021-10-19 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US11180517B2
(en)
|
2017-10-09 |
2021-11-23 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US12668605B2
(en)
|
2017-10-09 |
2026-06-30 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2588506B
(en)
*
|
2017-10-09 |
2022-07-06 |
Compass Pathfinder Ltd |
Psilocybin polymorphic form A, formulations and use in medicine
|
|
US12662498B2
(en)
|
2017-10-09 |
2026-06-23 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US11505564B2
(en)
|
2017-10-09 |
2022-11-22 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US12643917B2
(en)
|
2017-10-09 |
2026-06-02 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
JP2023024755A
(ja)
*
|
2017-10-09 |
2023-02-16 |
コンパス パスファインダー リミテッド |
シロシビン、異なる多形形態、中間体、調合物の調製及びそれらの使用
|
|
US11629159B2
(en)
|
2017-10-09 |
2023-04-18 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
IL311953B2
(en)
*
|
2017-10-09 |
2026-01-01 |
Compass Pathfinder Ltd |
Preparation of psilocybin, various polymorphic forms, intermediates, formulations and their use
|
|
US11851451B2
(en)
|
2017-10-09 |
2023-12-26 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2571696A
(en)
*
|
2017-10-09 |
2019-09-11 |
Compass Pathways Ltd |
Preparation of Psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
IL311953B1
(en)
*
|
2017-10-09 |
2025-09-01 |
Compass Pathfinder Ltd |
Preparation of psilocybin, various polymorphic forms, intermediates, formulations and their use
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US11939346B2
(en)
|
2017-10-09 |
2024-03-26 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
WO2019073379A1
(en)
*
|
2017-10-09 |
2019-04-18 |
Compass Pathways Limited |
PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIAIRES, FORMULATIONS AND THEIR USE
|
|
IL273883B1
(en)
*
|
2017-10-09 |
2024-05-01 |
Compass Pathfinder Ltd |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
IL273883B2
(en)
*
|
2017-10-09 |
2024-09-01 |
Compass Pathfinder Ltd |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
US12611418B2
(en)
|
2019-04-17 |
2026-04-28 |
Compass Pathfinder Limited |
Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US12447164B2
(en)
|
2019-04-17 |
2025-10-21 |
Compass Pathfinder Limited |
Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US11564935B2
(en)
|
2019-04-17 |
2023-01-31 |
Compass Pathfinder Limited |
Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US12433904B2
(en)
|
2019-04-17 |
2025-10-07 |
Compass Pathfinder Limited |
Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US11738035B2
(en)
|
2019-04-17 |
2023-08-29 |
Compass Pathfinder Limited |
Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US12377112B2
(en)
|
2019-04-17 |
2025-08-05 |
Compass Pathfinder Limited |
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
|
|
US11746088B2
(en)
|
2020-05-19 |
2023-09-05 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
US12110272B2
(en)
|
2020-05-19 |
2024-10-08 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
US11724985B2
(en)
|
2020-05-19 |
2023-08-15 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
US11958807B2
(en)
|
2020-05-19 |
2024-04-16 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
US12291499B2
(en)
|
2020-05-19 |
2025-05-06 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
US12240813B2
(en)
|
2020-05-19 |
2025-03-04 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
US11834410B2
(en)
|
2020-05-19 |
2023-12-05 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
WO2022000091A1
(en)
|
2020-06-30 |
2022-01-06 |
Field Trip Psychedelics Inc. |
Tryptamine prodrugs
|
|
EP4786000A2
(en)
|
2020-06-30 |
2026-08-05 |
Reunion Neuroscience, Inc. |
Tryptamine prodrugs
|
|
US12060328B2
(en)
|
2022-03-04 |
2024-08-13 |
Reset Pharmaceuticals, Inc. |
Co-crystals or salts of psilocybin and methods of treatment therewith
|
|
US12559458B2
(en)
|
2022-03-04 |
2026-02-24 |
Reset Pharmaceuticals, Inc. |
Co-crystals or salts of psilocin and methods of treatment therewith
|